Get startedLog in
    Picture of Neuland Laboratories logo

    NEULANDLAB — Neuland Laboratories Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Neuland Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue7,6279,3699,51111,91215,586
    Cost of Revenue
    Gross Profit3,1024,0494,2385,8568,573
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses6,9048,2738,5569,60911,552
    Operating Profit7231,0969552,3034,033
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes5291,0538222,1574,014
    Provision for Income Taxes
    Net Income After Taxes3958066381,6353,001
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income1628066381,6353,001
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income1628066381,6353,001
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS30.56350.8128248
    Dividends per Share